|
|
negative regulation of viral genome replication
|
GO:0045071 |
10 |
0.963
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.952
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.906
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.845
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.813
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.770
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.725
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.666
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.610
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.589
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.469
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.469
|
|
|
|
defense response to protozoan
|
GO:0042832 |
25 |
0.421
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.408
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.408
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.400
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.385
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.378
|
|
|
|
viral genome replication
|
GO:0019079 |
17 |
0.362
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.358
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.350
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
13 |
0.346
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.344
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.328
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.298
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.283
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.281
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.278
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.274
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.271
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
8 |
0.262
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.262
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.242
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.239
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.235
|
|
|
|
regulation of interleukin 4 biosynthetic process
|
GO:0045402 |
3 |
0.227
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.223
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.220
|
|
|
|
t helper 17 cell lineage commitment
|
GO:0072540 |
4 |
0.220
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
4 |
0.216
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.207
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.199
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.180
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.175
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.172
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.168
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.168
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.165
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.161
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.152
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.151
|
|
|
|
cellular response to interferon beta
|
GO:0035458 |
21 |
0.150
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.149
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.146
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.144
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.144
|
|
|
|
response to protozoan
|
GO:0001562 |
28 |
0.143
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.139
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.138
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.132
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
1 |
0.132
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.132
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.131
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.130
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.126
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.123
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.120
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.119
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.119
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.118
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.115
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.109
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.108
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.107
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.105
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.104
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.103
|
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
2 |
0.103
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.102
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.102
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.101
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.097
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.096
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.095
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.095
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.092
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.091
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.091
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.090
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.086
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.085
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.085
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.084
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.084
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.082
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.081
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.081
|
|
|
|
somatic recombination of immunoglobulin genes involved in immune response
|
GO:0002204 |
36 |
0.079
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.077
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.077
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.077
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.076
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.076
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.075
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.075
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.075
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.075
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.074
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.073
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.073
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.071
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.071
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.071
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.071
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.070
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.070
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.070
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.069
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.069
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.067
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.066
|
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.065
|
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.064
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.062
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.062
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.062
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.062
|
|
|
|
cd8 positive alpha beta t cell proliferation
|
GO:0035740 |
1 |
0.062
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.062
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.062
|
|
|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.061
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.060
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.060
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.060
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.059
|
|
|
|
mda 5 signaling pathway
|
GO:0039530 |
1 |
0.059
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.058
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.058
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.058
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.058
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.058
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.057
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.057
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.057
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.057
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.057
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.056
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.055
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.055
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.055
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.055
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.055
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.055
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.052
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.052
|
|
|
|
t cell lineage commitment
|
GO:0002360 |
13 |
0.052
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.051
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.050
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.049
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.049
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.048
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.048
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.047
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.047
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.046
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.045
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.045
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.045
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.044
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.044
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.044
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.044
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.044
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.044
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.043
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.042
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.042
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.042
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.041
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.041
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.041
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.041
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.040
|
|
|
|
toll like receptor 9 signaling pathway
|
GO:0034162 |
6 |
0.040
|
|
|
|
hair follicle cell proliferation
|
GO:0071335 |
3 |
0.039
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.039
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.039
|
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.039
|
|
|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.039
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
16 |
0.039
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.039
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
10 |
0.038
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.037
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.037
|
|
|
|
negative regulation of interferon beta production
|
GO:0032688 |
3 |
0.036
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.036
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.036
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.036
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.035
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.035
|
|
|
|
negative regulation of t cell differentiation
|
GO:0045581 |
23 |
0.035
|
|
|
|
regulation of cd8 positive alpha beta t cell proliferation
|
GO:2000564 |
1 |
0.035
|
|
|
|
regulation of toll like receptor 9 signaling pathway
|
GO:0034163 |
3 |
0.035
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.035
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.034
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.034
|
|
|
|
positive regulation of cytokine production involved in immune response
|
GO:0002720 |
19 |
0.034
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.034
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.034
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.033
|
|
|
|
regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway
|
GO:0039531 |
2 |
0.033
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.033
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.032
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.032
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.032
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.032
|
|
|
|
positive regulation of myelination
|
GO:0031643 |
5 |
0.032
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.031
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.031
|
|
|
|
negative regulation of interferon beta biosynthetic process
|
GO:0045358 |
1 |
0.031
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.031
|
|
|
|
type 2 immune response
|
GO:0042092 |
23 |
0.031
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.031
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.030
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.030
|
|
|
|
zygote asymmetric cell division
|
GO:0010070 |
2 |
0.030
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.030
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.030
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.030
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.030
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.030
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.029
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.029
|
|
|
|
positive regulation of toll like receptor 9 signaling pathway
|
GO:0034165 |
2 |
0.029
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.029
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.029
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.028
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.028
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.028
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.028
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.028
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.027
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.027
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.026
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.026
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.026
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.026
|
|
|
|
t helper 17 cell differentiation
|
GO:0072539 |
7 |
0.026
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.026
|
|
|
|
response to type i interferon
|
GO:0034340 |
12 |
0.026
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.026
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.026
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.026
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.026
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.026
|
|
|
|
cd4 positive alpha beta t cell lineage commitment
|
GO:0043373 |
6 |
0.026
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.026
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.026
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.025
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.025
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.025
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.025
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.025
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.025
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.025
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.025
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.025
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.024
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.024
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.024
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.024
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.024
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.024
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.023
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.023
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.023
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.023
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.023
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.023
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.023
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.023
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.023
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.023
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.023
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.023
|
|
|
|
regulation of neutrophil mediated killing of gram negative bacterium
|
GO:0070951 |
1 |
0.022
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.022
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.022
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.021
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.021
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.021
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.021
|
|
|
|
negative regulation of defense response to virus
|
GO:0050687 |
6 |
0.021
|
|
|
|
positive regulation of t helper 2 cell cytokine production
|
GO:2000553 |
3 |
0.021
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.021
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.021
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.021
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.021
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.020
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.020
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.020
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.020
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.020
|
|
|
|
negative regulation of rig i signaling pathway
|
GO:0039536 |
2 |
0.020
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.020
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.020
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.020
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.020
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.020
|
|
|
|
cd4 positive or cd8 positive alpha beta t cell lineage commitment
|
GO:0043369 |
8 |
0.020
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.020
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.020
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.020
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.019
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.019
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.019
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.019
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.019
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.019
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
|
negative regulation of defense response to virus by host
|
GO:0050689 |
1 |
0.019
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.019
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.019
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.019
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.019
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.019
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.019
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.019
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.019
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.019
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
regulation of cd8 positive alpha beta t cell activation
|
GO:2001185 |
3 |
0.019
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.018
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.018
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.018
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.018
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.018
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.018
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.018
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.018
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.018
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.018
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.018
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.018
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.018
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.018
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.018
|
|
|
|
positive regulation of response to biotic stimulus
|
GO:0002833 |
15 |
0.018
|
|
|
|
production of small rna involved in gene silencing by rna
|
GO:0070918 |
6 |
0.018
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.018
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.018
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.017
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.017
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.017
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.017
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.017
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.017
|
|
|
|
regulation of interleukin 2 secretion
|
GO:1900040 |
6 |
0.017
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.017
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.017
|
|
|
|
regulation of defense response to fungus
|
GO:1900150 |
1 |
0.017
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.017
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.017
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.017
|
|
|
|
pre mirna processing
|
GO:0031054 |
3 |
0.017
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
26 |
0.017
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.017
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.016
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.016
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.016
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.016
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.016
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.016
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.016
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.015
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.015
|
|
|
|
translation
|
GO:0006412 |
93 |
0.015
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.015
|
|
|
|
interleukin 2 secretion
|
GO:0070970 |
7 |
0.015
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.015
|
|
|
|
positive regulation of interleukin 12 production
|
GO:0032735 |
21 |
0.015
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.015
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.015
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.015
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.015
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.015
|
|
|
|
alpha beta t cell lineage commitment
|
GO:0002363 |
7 |
0.015
|
|
|
|
production of mirnas involved in gene silencing by mirna
|
GO:0035196 |
6 |
0.015
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.015
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.015
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.015
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.015
|
|
|
|
myd88 independent toll like receptor signaling pathway
|
GO:0002756 |
3 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.015
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.015
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.014
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.014
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.014
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.014
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.014
|
|
|
|
regulation of alpha beta t cell proliferation
|
GO:0046640 |
18 |
0.014
|
|
|
|
positive regulation of antimicrobial peptide biosynthetic process
|
GO:0002807 |
1 |
0.014
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.014
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.014
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.014
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.014
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.014
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.014
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.014
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.014
|
|
|
|
chemokine production
|
GO:0032602 |
34 |
0.014
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.014
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.014
|
|
|
|
regulation of regulatory t cell differentiation
|
GO:0045589 |
7 |
0.014
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.013
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.013
|
|
|
|
regulation of myd88 independent toll like receptor signaling pathway
|
GO:0034127 |
1 |
0.013
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.013
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.013
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
10 |
0.013
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.013
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.013
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.013
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.013
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.013
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.013
|
|
|
|
pyrimidine containing compound catabolic process
|
GO:0072529 |
3 |
0.013
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.013
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.013
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.013
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.013
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.013
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.013
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.013
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.013
|
|
|
|
ganglion development
|
GO:0061548 |
13 |
0.013
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.013
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.013
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.013
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.013
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.013
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.013
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.013
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.013
|
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.012
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.012
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
